| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 3 securities · passive | ||||||
|
Celularity Inc
13G/A
CELU · 151190105
|
1.9% |
2/14/2025
Event 12/31/2024
|
||||
| Bristol Myers Squibb Co | 1.9% | |||||
| Celgene Corporation | 1.9% | |||||
|
Q32 Bio Inc.
13G/A
QTTB · 746964105
|
1.6% |
2/14/2025
Event 12/31/2024
|
||||
|
Compugen Ltd.
13G/A
CGEN · M25722105
|
2.1% |
2/14/2025
Event 12/31/2024
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.